{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:52:06Z","timestamp":1785887526256,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00192-020-04451-w","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T07:38:12Z","timestamp":1595921892000},"page":"1213-1219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Onabotulinumtoxin a injection with or without hydrodistension for treatment of bladder pain syndrome"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8522-4748","authenticated-orcid":false,"given":"Laura","family":"Mateu Arrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gutierrez Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Errando-Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"4451_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","volume":"53","author":"JP van de Merwe","year":"2008","unstructured":"van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60\u20137.","journal-title":"Eur Urol"},{"key":"4451_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/nau.22475","volume":"33","author":"EL Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou EL, Doumouchtsis SK. Challenges and current evidence on the management of bladder pain syndrome. Neurourol Urodyn. 2014;33:1193\u2013201.","journal-title":"Neurourol Urodyn"},{"key":"4451_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00192-012-1832-x","volume":"24","author":"A Gafni-Kane","year":"2013","unstructured":"Gafni-Kane A, Botros SM, Du H, et al. Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2013;24:303\u201311.","journal-title":"Int Urogynecol J"},{"key":"4451_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-011-0785-x","volume":"30","author":"J Nordling","year":"2012","unstructured":"Nordling J, Fall M, Hanno P. Global concepts of bladder pain syndrome (interstitial cystitis). World J Urol. 2012;30:457\u201364.","journal-title":"World J Urol"},{"key":"4451_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.urology.2014.09.012","volume":"85","author":"A Chennamsetty","year":"2015","unstructured":"Chennamsetty A, Khourdaji I, Goike J, et al. Electrosurgical management of Hunner ulcers in a referral center\u2019s interstitial cystitis population. Urology. 2015;85:74\u20138.","journal-title":"Urology."},{"key":"4451_CR6","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/nau.23493","volume":"37","author":"MS Rahnama\u2019i","year":"2018","unstructured":"Rahnama\u2019i MS, Marcelissen T, Apostolidis A, et al. The efficacy of botulinum toxin a and sacral neuromodulation in the management of interstitialcystitis (IC)\/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank. Bristol Neurourol Urodyn. 2018;37:S99\u2013S107.","journal-title":"Bristol Neurourol Urodyn"},{"key":"4451_CR7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","volume":"179","author":"A Giannantoni","year":"2008","unstructured":"Giannantoni A, Porena M, Costantini E, et al. Botulinum a toxin intravesical injection in patients with painful bladder syndrome: 1-year follow up. J Urol. 2008;179:1031\u20134.","journal-title":"J Urol"},{"key":"4451_CR8","first-page":"998","volume":"199","author":"RA Pinto","year":"2018","unstructured":"Pinto RA, Costa D, Morgado A, et al. Intratrigonal onabotulinumtoxinA improves bladder symptoms and quality of life in patients with bladder pain syndrome\/interstitial cystitis: a pilot, single center, randomized, double-blind. Placebo Controlled Trial J Urol. 2018;199:998\u20131003.","journal-title":"Placebo Controlled Trial J Urol"},{"key":"4451_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","volume":"70","author":"HT Liu","year":"2007","unstructured":"Liu HT, Kuo HC. Intravesical botulinum toxin a injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology. 2007;70:463\u20138.","journal-title":"Urology."},{"key":"4451_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/nau.22760","volume":"35","author":"HC Kuo","year":"2016","unstructured":"Kuo HC, Jiang YH, Tsai YC, et al. Intravesical botulinum toxin\u2014a injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016;35:609\u201314.","journal-title":"Neurourol Urodyn"},{"key":"4451_CR11","first-page":"197","volume":"15","author":"SD Chung","year":"2012","unstructured":"Chung SD, Kuo YC, Kuo HC. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. Pain Physician. 2012;15:197\u2013202.","journal-title":"Pain Physician"},{"key":"4451_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","volume":"104","author":"HC Kuo","year":"2009","unstructured":"Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type a injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome. BJU Int. 2009;104:657\u201361.","journal-title":"BJU Int"},{"key":"4451_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2007.02.067","volume":"70","author":"KM Peters","year":"2007","unstructured":"Peters KM, Carrico DJ, Kalinowski SE, et al. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70:16\u20138.","journal-title":"Urology."},{"key":"4451_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1442-2042.2008.02208.x","volume":"16","author":"Y Homma","year":"2009","unstructured":"Homma Y, Ueda T, Ito T, et al. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int J Urol. 2009;16:4\u201316.","journal-title":"Int J Urol"},{"key":"4451_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.urology.2008.05.033","volume":"72","author":"S Colman","year":"2008","unstructured":"Colman S, Chapple C, Nitti V, et al. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder. Urology. 2008;72:803\u20137.","journal-title":"Urology."},{"key":"4451_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.medcli.2011.11.013","volume":"140","author":"C Errando-Smet","year":"2013","unstructured":"Errando-Smet C, Ruiz MA, Villacampa-Aub\u00e1 F, et al. Spanish cultural adaptation and psychometrical validation of the treatment benefit scale (TBS) in the symptomatic treatment of overactive bladder. Med Clin (Barc). 2013;140:6\u201313.","journal-title":"Med Clin (Barc)"},{"key":"4451_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classifcation of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"4451_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00192-013-2267-8","volume":"25","author":"J Manning","year":"2014","unstructured":"Manning J, Dwyer P, Rosamilia A, et al. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum a (AboBTXA) among women with refractory interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2014;25:593\u20139.","journal-title":"Int Urogynecol J"},{"key":"4451_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP, Radziszewski P, Borkowski A, et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64:871\u20135.","journal-title":"Urology."},{"key":"4451_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/iju.12833","volume":"22","author":"Y Akiyama","year":"2015","unstructured":"Akiyama Y, Nomiya A, Niimi A, et al. Botulinum toxin type a injection for refractory interstitial cystitis: a randomized comparative study and predictors of treatment response. Int J Urol. 2015;22:835\u201341.","journal-title":"Int J Urol"},{"key":"4451_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","volume":"177","author":"G Karsenty","year":"2007","unstructured":"Karsenty G, Elzayat E, Delapparent T, et al. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol. 2007;177:1011\u20134.","journal-title":"J Urol"},{"key":"4451_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.juro.2012.09.027","volume":"189","author":"R Pinto","year":"2013","unstructured":"Pinto R, Lopes T, Silva J, et al. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome\/interstitial cystitis. J Urol. 2013;189:548\u201353.","journal-title":"J Urol"},{"key":"4451_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/156720110790396463","volume":"7","author":"A Giannantoni","year":"2010","unstructured":"Giannantoni A, Mearini E, Del Zingaro M, et al. Two-year efficacy and safety of botulinum a toxin intravesical injections in patients affected by refractory painful bladder syndrome. Curr Drug Deliv. 2010;7:1\u20134.","journal-title":"Curr Drug Deliv"},{"key":"4451_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ijcp.12113","volume":"67","author":"HC Kuo","year":"2013","unstructured":"Kuo HC. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis\/bladder pain syndrome. Int J Clin Pract. 2013;67:427\u201334.","journal-title":"Int J Clin Pract"},{"key":"4451_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","volume":"198","author":"YC Chuang","year":"2017","unstructured":"Chuang YC, Kuo HC. A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome. J Urol. 2017;198:376\u201382.","journal-title":"J Urol"},{"key":"4451_CR26","first-page":"34","volume":"29","author":"GD Webster","year":"1987","unstructured":"Webster GD, Galloway N. Surgical treatment of interstitial cystitis. Indications, techniques, and results. Urology. 1987;29:34\u20139.","journal-title":"Urology."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04451-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:16:35Z","timestamp":1627427795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04451-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4451"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04451-w","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Funding: No funding was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclaimer\/conflicts of interest"}}]}}